Children and adolescents with panic disorder|My homework helper

 For this Assignment, you consider these questions and others as you explore FDA-approved (“on label”) pharmacological treatments, non-FDA-approved (“off-label”) pharmacological treatments, and nonpharmacological treatments for disorders in children and adolescents.

• Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your assigned disorder in children and adolescents.
• Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
• Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
• Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.
• Children and adolescents with panic disorder.

SOLUTION

For children and adolescents with panic disorder, the following are one recommended FDA-approved drug, one off-label drug, and one nonpharmacological intervention: FDA-approved drug: Fluoxetine (Prozac) is an FDA-approved selective serotonin reuptake inhibitor (SSRI) for children aged 8 years and older with panic disorder. The benefits of Fluoxetine include the alleviation of panic symptoms such as intense fear, palpitations, and sweating. The risks of Fluoxetine include nausea, vomiting, headache, dizziness, and suicidal thoughts.